New diphenylphosphane derivatives of ketoconazole are promising antifungal agents
Four new derivatives of ketoconazole ( Ke ) were synthesized: diphenylphosphane ( KeP ), and phosphane chalcogenides: oxide ( KeOP ), sulphide ( KeSP ) and selenide ( KeSeP ). These compounds proved to be promising antifungal compounds towards Saccharomyces cerevisiae and Candida albicans , especial...
Saved in:
Published in | Scientific reports Vol. 9; no. 1; pp. 16214 - 14 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
07.11.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Four new derivatives of ketoconazole (
Ke
) were synthesized: diphenylphosphane (
KeP
), and phosphane chalcogenides: oxide (
KeOP
), sulphide (
KeSP
) and selenide (
KeSeP
). These compounds proved to be promising antifungal compounds towards
Saccharomyces cerevisiae
and
Candida albicans
, especially in synergy with fluconazole. Simulations of docking to the cytochrome P450 14α-demethylase (azoles’ primary molecular target) proved that the new
Ke
derivatives are capable of inhibiting this enzyme by binding to the active site. Cytotoxicity towards hACSs (human adipose-derived stromal cells) of the individual compounds was studied and the IC
50
values were higher than the MIC
50
for
C
.
albicans
and
S
.
cerevisiae
.
KeP
and
KeOP
increased the level of the p21 gene transcript but did not change the level of p53 gene transcript, a major regulator of apoptosis, and decreased the mitochondrial membrane potential. Taken together, the results advocate that the new ketoconazole derivatives have a similar mechanism of action and block the lanosterol 14α-demethylase and thus inhibit the production of ergosterol in
C
.
albicans
membranes. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-019-52525-7 |